CRA was retained by a non-profit organization to provide an expert opinion on damages in a breach of contract arbitration concerning a funding agreement relating to a cystic fibrosis therapy. CRA quantified the amount owed to the plaintiff in connection with a milestone payment tied to the value of technology developed under the funding agreement. CRA provided a report on economic damages as well as hearing testimony.
Were shareholders harmed by Senate Bill 21’s amendments to the Delaware General Corporation Law?
Delaware Governor Meyer signed into law Senate Bill 21 (SB21) in March 2025, updating Delaware’s corporate law, with some of the key provisions including safe...